These publications were authored or co-authored by Quest Diagnostics staff.

Ubiquitin-proteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver disease.

Authors: Qu KZ, Zhang K, Ma W, Li H, Wang X, Zhang X, Giles F, Lai M, Afdhal NH, Albitar M.
J Gastroenterol Hepatol. 2011;26:751-758.

Specialties: Hematology/Hemostasis/Thrombosis, Oncology

Circulating microRNAs as biomarkers for hepatocellular carcinoma.

Authors: Qu KZ, Zhang K, Li H, Afdhal NH, Albitar M.
J Clin Gastroenterol. 2011;45:355-360.

Specialties: Oncology, Pathology, Laboratory Medicine

High incidence of IDH mutations in acute myeloid leukaemia with cuplike nuclei.

Authors: Rakheja D, Konoplev S, Su M, Wheeler D, Muzny DM, Ruvolo VR, Collins R, Karandikar NJ, Andreeff M, Medeiros LJ, Chen W.
Br J Haematol. 2011;155:125-128.

Specialties: Internal Medicine, Oncologists, Pathologists, Women's Health/OB/GYN

Fluorescence in situ hybridization and K-ras analyses improve diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses.

Authors: Reicher S, Boyar FZ, Albitar M, Sulcova V, Agersborg S, Nga V, Zhou Y, Li G, Venegas R, French SW, Chung DS, Stabile BE, Eysselein VE, Anguiano A.
Pancreas. 2011;40:1057-1062.

Specialties: Gastroenterology, Pathology, Anatomic

Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: results of a phase 1/2 study.

Authors: Richardson PG, Chanan-Khan AA, Lonial S, Krishnan AY, Carroll MP, Alsina M, Albitar M, Berman D, Messina M, Anderson KC.
Br J Haematol. 2011;153:729-740.

Specialties: Dermatology, Hematologists, Oncologists, Oncology

Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer.

Authors: Sanders HR, Li HR, Bruey JM, Scheerle JA, Meloni-Ehrig AM, Kelly JC, Novick C, Albitar M
Cancer Genet. 2011;204:45-52.

Specialties: Oncologists, Pathologists, Pathology, Laboratory Medicine

The contribution of a 9p21.3 variant, a KIF6 variant, and C-reactive protein to predicting risk of myocardial infarction in a prospective study.

Authors: Shiffman D, O'Meara ES, Rowland CM, Louie JZ, Cushman M, Tracy RP, Devlin JJ, Psaty BM.
BMC Cardiovasc Disord. 2011;11:10.

Specialties: Cardiology, Internal Medicine

Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals.

Authors: Shikuma CM, Ribaudo HJ, Zheng Y, Gulick RM, Meyer WA, Tashima KT, Bastow B, Kuritzkes DR, Glesby MJ.
AIDS Res Hum Retroviruses. 2011;27:461-468.

Specialties: Cardiology, Infectious Disease, Internal Medicine

Multiple myeloma: current perspectives.

Authors: Slovak ML.
Clin Lab Med. 2011;31:699-724, x.

Specialties: Hematology/Hemostasis/Thrombosis, Oncology